BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• Biotech Beach

  Mesa Biotech to Demonstrate New Accula Molecular POC Testing Platform at Medica 2018

  Company to Participate in USA Corporate Executive Office Program

  November 16, 2018

   · 

  2 min read
• Polarean Imaging Plc Company Update

  Polarean Imaging plc provides shareholders with the following update on Company progress:

  November 16, 2018

   · 

  3 min read
• Business

  Oxford Immunotec Schedules Third Quarter 2018 Earnings Release and Business Update Conference Call for November 9, 2018

  Oxford Immunotec Global PLC today announced that it plans to release third quarter 2018 financial results prior to market open on Friday, November 9, 2018.

  November 16, 2018

   · 

  1 min read
• 

  Policy

  As Brexit Looms, Biopharma Industry Prepares for the Worst

  The UK’s exit from the European Union, Brexit, will impact numerous industries in the UK and Europe, but the biopharma industry has its own unique challenges.

  November 16, 2018

   · 

  4 min read

   · 

  Mark Terry
• 

  Business

  BioSpace Movers and Shakers for Nov. 19

  Companies bolstered their leadership with additions to boards of directors and c-suite offices.

  November 16, 2018

   · 

  4 min read

   · 

  Alex Keown
• Business

  Regenstrief, IU Public Health Name Dixon Director of Public Health Informatics

  Joint expertise to help tackle potential problems ranging from disease outbreaks to bioterrorism

  November 16, 2018

   · 

  4 min read
• Policy

  ACACIA PHARMA RESUBMITS BARHEMSYS™ NEW DRUG APPLICATION

  This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No 596/2014.

  November 16, 2018

   · 

  4 min read
• 

  Business

  Ultragenyx Reports Third Quarter 2018 Financial Results and Corporate Update

  Ultragenyx Pharmaceutical Inc. today reported its financial results and corporate update for the quarter ended September 30, 2018.

  November 16, 2018

   · 

  11 min read
• Business

  Acacia Pharma Group plc Unaudited Results for the nine months to 30 September 2018

  Acacia Pharma Group plc announces its unaudited results for the nine months to 30 September 2018 to provide an update on current trading and its cash position.

  November 16, 2018

   · 

  2 min read
• Biotech Bay

  Market Entrants Offering Digitized Mass Spectrometry Solutions Gain a Competitive Edge over Traditional Vendors

  Pharmaceuticals and food & beverage industries generate significant demand for advanced MS solutions, finds Frost & Sullivan

  November 16, 2018

   · 

  2 min read